← Back to Search

Behavioural Intervention

Guided Imagery for Pain after Breast Surgery

N/A
Recruiting
Led By Uzondu Osuagwu, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients aged 18 to 70 years
Post-mastectomy pain syndrome lasting more than 4 weeks
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

This trial is testing whether using guided imagery and deep breathing techniques can help with pain management in patients who have post-mastectomy pain syndrome.

Who is the study for?
This trial is for women aged 18-70 with chronic pain after mastectomy (lasting over 3 months), scoring between 5-10 on pain severity or interference. Participants must have had a mastectomy within the last year, speak English, consent to the study's terms, and if taking anxiety or depression meds, be on a stable dose.Check my eligibility
What is being tested?
The study aims to determine if guided imagery and deep breathing can alleviate pain in women with post-mastectomy pain syndrome. It involves two groups: one practicing these techniques (Intervention Group) and another not using them (Control Group).See study design
What are the potential side effects?
Since this trial focuses on non-invasive techniques like guided imagery and deep breathing exercises, there are minimal expected side effects compared to drug treatments. However, individual experiences may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old.
Select...
I have had pain after mastectomy for more than 4 weeks.
Select...
I experience pain from my condition that affects my daily activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain

Trial Design

2Treatment groups
Experimental Treatment
Group I: Group 2 ( The Control Group)Experimental Treatment1 Intervention
Participants will not receive any relaxation techniques. Participants will receive the current standard of care.
Group II: Group 1 (The Intervention Group)Experimental Treatment1 Intervention
Participants will receive guided imagery and deep breathing technique exercises.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,966 Previous Clinical Trials
1,804,786 Total Patients Enrolled
15 Trials studying Pain
1,359 Patients Enrolled for Pain
Uzondu Osuagwu, MDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

The Intervention Group (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05408741 — N/A
Pain Research Study Groups: Group 1 (The Intervention Group), Group 2 ( The Control Group)
Pain Clinical Trial 2023: The Intervention Group Highlights & Side Effects. Trial Name: NCT05408741 — N/A
The Intervention Group (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05408741 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are currently participating in this trial experiment?

"Affirmative. The information on clinicaltrials.gov denotes that this study is currently enrolling participants, with the initial post dated June 6th 2022 and the most recent update made to its page also occurring on that day. 62 individuals are needed from a single location for this trial."

Answered by AI

Are any additional participants being enrolled in this research study?

"According to clinicaltrials.gov, this research is still recruiting patients; the trial was posted on June 6th 2022 and updated on the same day."

Answered by AI
~17 spots leftby Dec 2024